[1]刘嘉豪,李琳.基于肠道菌群探讨心血管疾病的中医辨治[J].中国中医药信息杂志,2021,28(9):11-14.[doi:10.19879/j.cnki.1005-5304.202009123]
 LIU Jiahao,LI Lin.TCM Syndrome Differentiation and Treatment of Cardiovascular Diseases Based on Intestinal Flora[J].zhongguo zhongyiyao xinxi zazhi,2021,28(9):11-14.[doi:10.19879/j.cnki.1005-5304.202009123]
点击复制

基于肠道菌群探讨心血管疾病的中医辨治

参考文献/References:

[1] GARCIA-RIOS A, TORRES-PEÑA J D, PEREZ-JIMENEZ F, et al. Gut microbiota:a new marker of cardiovascular disease[J]. Curr Pharm Des,2017,23(22):3233-3238.

[2] RICHARDS E M, PEPINE C J, RAIZADA M K, et al. The gut, its microbiome, and hypertension[J]. Curr Hypertens Rep,2017,19(4):36.

[3] XIE J, LU W, ZHONG L, et al. Alterations in gut microbiota of abdominal aorticaneurysm mice[J]. BMC Cardiovasc Disord,2020, 20(1):32.

[4] LE ROY T, LÉCUYER E, CHASSAING B, et al. The intestinal microbiota regulates host cholesterol homeostasis[J]. BMC Biol, 2019,17(1):94.

[5] LIU Z, LI J, LIU H, et al. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease[J]. Atherosclerosis,2019,284:121-128.

[6] KURILSHIKOV A, VAN DEN MUNCKHOF I, CHEN L, et al. Gut microbial associations to plasma metabolites linked to cardiovascular phenotypes and risk[J]. Circ Res,2019,124(12):1808-1820.

[7] ZHU Y, JAMESON E, CROSATTI M, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota[J]. Proc Natl Acad Sci U S A,2014,111(11):4268-4273.

[8] KOETH R A, LAM-GALVEZ B R, KIRSOP J, et al. L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans[J]. J Clin Invest,2019,129(1):373-387.

[9] ZHU W. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J]. Cell,2016,165:111-124.

[10] ZHU W, WANG Z, TANG W, et al. Gut microbe-generated trimethylamine N-oxide from dietary choline is prothrombotic in subjects[J]. Circulation,2017,135(17):1671-1673.

[11] ODONOVAN A N, HERISSON F M, FOUHY F, et al. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF[J]. Am J Physiol Heart Circ Physiol,2020,318(3):H590-H603.

[12] YANG T, SANTISTEBAN M M, RODRIGUEZ V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension,2015,65(6):1331-1340.

[13] ROBLES-VERA I, TORAL M, DE LA VISITACIÓN N, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension:role of short-chain fatty acids[J]. Mol Nutr Food Res,2020,64(6):e1900616.

[14] LIU J, LI T, WU H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4+ T cell induced-type I inflammation[J]. Biomedicine & Pharmacotherapy,2019,112:108580.

[15] NATARAJAN N, HORI D, FLAVAHAN S, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41[J]. Physiol Genomics,2016,48(11):826-834.

[16] KAYE D M, SHIHATA W A, JAMA H A, et al. Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease[J]. Circulation,2020, 141(17):1393-1403.

[17] ANLU W, DONGCHENG C, HE Z, et al. Using herbal medicine to target the microbiota-metabolism-immunity axis as possible therapy for cardiovascular disease[J]. Pharmacol Res,2019,142:205-222.

[18] SINGH A B, LIU J. Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice[J]. Sci Rep,2019,9(1):15641.

[19] ZHANG X, ZHAO Y, XU J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats[J]. Scientific Reports,2015,5(6):14405.

[20] CHANG C J, LIN C S, LU C C, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota[J]. Nat Commun,2015,6:7489.

[21] ZHOU S S, AUYEUNG K K, YIP K M, et al. Stronger anti-obesity effect of white ginseng over red ginseng and the potential mechanisms involving chemically structural/compositional specificity to gut microbiota[J]. Phytomedicine,2020,74:152761.

[22] CHEN M L, LONG Y, YONG Z, et al. Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota[J]. mBio,2016,7(2):e02210-e02215.

[23] GUO Y, DING P H, LIU L J, et al. Gegen Qinlian decoction attenuates high-fat diet-induced steatohepatitis in rats via gut microbiota[J]. Evid Based Complement Alternat Med,2018,2018:7370891.

[24] YU X, ZHANG X, JIN H, et al. Zhenganxifeng decoction affects gut microbiota and reduces blood pressure via renin-angiotensin system[J]. Biol Pharm Bull,2019,42(9):1482-1490.

相似文献/References:

[1]唐敏,唐晓玲,指导:陈荣.三七总皂苷治疗心血管疾病临床研究进展[J].中国中医药信息杂志,2006,13(9):93.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(9):93.
[2]史琦,指导:王阶.灯盏花素治疗心血管疾病基础研究近况[J].中国中医药信息杂志,2009,16(12):98.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):98.
[3]刘秀娟,指导:徐承秋.徐承秋治疗胸痹心痛临证经验[J].中国中医药信息杂志,2008,15(9):87.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):87.
[4]徐莺,杨青,朱海燕,等.稳心颗粒治疗心血管疾病研究进展[J].中国中医药信息杂志,2011,18(12):100.[doi:10.3969/j.issn.1005-5304.2011.12.048]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):100.[doi:10.3969/j.issn.1005-5304.2011.12.048]
[5]许朝霞,刘腾飞,王忆勤,等.基于隐结构模型分析的心血管疾病中医问诊证候分类研究[J].中国中医药信息杂志,2012,19(3):9.[doi:10.3969/j.issn.1005-5304.2012.03.005]
 XU Zhao-xia,LIU Teng-fei,WANG Yi-qin,et al.Syndromes Classification of TCM Inquiry about Cardiovascular Disease Based on the Analysis of Latent Structural Model[J].zhongguo zhongyiyao xinxi zazhi,2012,19(9):9.[doi:10.3969/j.issn.1005-5304.2012.03.005]
[6]成泽东,陈以国,张涛.温和灸对慢性疲劳大鼠肠道菌群的影响[J].中国中医药信息杂志,2013,20(1):45.[doi:10.3969/j.issn.1005-5304.2013.01.017]
 CHENG Ze-dong,CHEN Yi-guo,ZHANG Tao.Influence of Mild Moxibustion on Intestinal Microflora of Chronic Fatigue Rats[J].zhongguo zhongyiyao xinxi zazhi,2013,20(9):45.[doi:10.3969/j.issn.1005-5304.2013.01.017]
[7]张慧玲,武玉鹏,白崇智,等.枳朴方中空栓对术后肠麻痹大鼠肠道屏障功能的影响[J].中国中医药信息杂志,2013,20(1):49.[doi:10.3969/j.issn.1005-5304.2013.01.019]
 ZHANG Hui-ling,WU Yu-peng,BAI Chong-zhi,et al.Effect of Zhipu Recipe Hollow-type Suppositories on Intestinal Barrier Function in Postoperative Enteroparalysis Rats[J].zhongguo zhongyiyao xinxi zazhi,2013,20(9):49.[doi:10.3969/j.issn.1005-5304.2013.01.019]
[8]李颖,李文娟,丁慧,等.王昀运用温阳益气活血法治疗心血管疾病经验[J].中国中医药信息杂志,2009,16(10):85.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):85.
[9]夏小燕,居文政,谈恒山.肠道菌群对中药皂苷类成分的代谢研究进展[J].中国中医药信息杂志,2008,15(2):96.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):96.
[10]李格,谷万里,史载祥.大蒜素治疗心血管疾病临床与实验研究进展[J].中国中医药信息杂志,2008,15(12):104.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):104.

备注/Memo

基金项目:湖南省教育厅项目(18B235)

更新日期/Last Update:

2021-08-17